Literature DB >> 26382576

Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Igor A Schepetkin1, Andrei I Khlebnikov2, Liliya N Kirpotina1, Mark T Quinn3.   

Abstract

Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases. To date, a variety of natural and synthetic molecules have been identified as FPR1 ligands. Here, we review current knowledge on natural products and natural product-inspired small molecules reported to antagonize and/or inhibit the FPR1-mediated responses. Based on this literature, additional screening of selected commercially available natural compounds for their ability to inhibit fMLF-induced Ca(2+) mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review. The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ca(2+) flux; Formyl peptide receptor 1; Molecular modeling; Natural compound; Neutrophil; Neutrophil elastase; Receptor antagonist; Superoxide anion radical

Mesh:

Substances:

Year:  2015        PMID: 26382576      PMCID: PMC4791210          DOI: 10.1016/j.intimp.2015.08.036

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  212 in total

1.  Tauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine.

Authors:  U Beuers; M Thiel; H Bardenheuer; G Paumgartner
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

2.  G protein-coupled chemoattractant receptors regulate Lyn tyrosine kinase.Shc adapter protein signaling complexes.

Authors:  A Ptasznik; A Traynor-Kaplan; G M Bokoch
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

Review 3.  Naturally occurring and synthetic agents as potential anti-inflammatory and immunomodulants.

Authors:  Nighat Sultana; Zafar Saeed Saify
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2012

4.  Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils.

Authors:  J P Wang; M F Hsu; S L Raung; L C Chang; L T Tsao; P L Lin; C C Chen
Journal:  J Pharm Pharmacol       Date:  1999-03       Impact factor: 3.765

5.  Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA.

Authors:  F Boulay; M Tardif; L Brouchon; P Vignais
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

Review 6.  Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities.

Authors:  Konstantina C Fylaktakidou; Dimitra J Hadjipavlou-Litina; Konstantinos E Litinas; Demetrios N Nicolaides
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

7.  Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets.

Authors:  H Salari; P Braquet; P Borgeat
Journal:  Prostaglandins Leukot Med       Date:  1984-01

8.  (2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.

Authors:  Yi-Jia Huang; Ih-Sheng Chen; Ching-Ping Tseng; Yuan-Ji Day; Yin-Chou Lin; Chang-Hui Liao
Journal:  Biochem Pharmacol       Date:  2007-10-06       Impact factor: 5.858

9.  Potent inhibition of human neutrophil activations by bractelactone, a novel chalcone from Fissistigma bracteolatum.

Authors:  Yang-Chang Wu; Munisamy Sureshbabu; Yao-Ching Fang; Yi-Hsiu Wu; Yu-Hsuan Lan; Fang-Rong Chang; Ya-Wen Chang; Tsong-Long Hwang
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-30       Impact factor: 4.219

Review 10.  Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils.

Authors:  Rita Selvatici; Sofia Falzarano; Adriano Mollica; Susanna Spisani
Journal:  Eur J Pharmacol       Date:  2006-03-03       Impact factor: 4.432

View more
  14 in total

1.  4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.

Authors:  Liliya N Kirpotina; Igor A Schepetkin; Andrei I Khlebnikov; Olga I Ruban; Yunjun Ge; Richard D Ye; Douglas J Kominsky; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2017-07-08       Impact factor: 5.858

2.  Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists.

Authors:  Margherita Mastromarino; Liliya N Kirpotina; Igor A Schepetkin; Mark T Quinn; Enza Lacivita; Marcello Leopoldo
Journal:  Medchemcomm       Date:  2019-10-07       Impact factor: 3.597

3.  The Antibody Receptor Fc Gamma Receptor IIIb Induces Calcium Entry via Transient Receptor Potential Melastatin 2 in Human Neutrophils.

Authors:  Omar Rafael Alemán; Nancy Mora; Carlos Rosales
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

Review 4.  Marine Natural Product Inhibitors of Neutrophil-Associated Inflammation.

Authors:  Chun-Yu Chen; Yung-Fong Tsai; Wen-Yi Chang; Shun-Chin Yang; Tsong-Long Hwang
Journal:  Mar Drugs       Date:  2016-07-26       Impact factor: 5.118

5.  The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.

Authors:  Igor Snapkov; Carl Otto Öqvist; Yngve Figenschau; Per Kogner; John Inge Johnsen; Baldur Sveinbjørnsson
Journal:  BMC Cancer       Date:  2016-07-18       Impact factor: 4.430

6.  Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Authors:  Maria Vincenza Carriero; Katia Bifulco; Vincenzo Ingangi; Susan Costantini; Giovanni Botti; Concetta Ragone; Michele Minopoli; Maria Letizia Motti; Domenica Rea; Giosuè Scognamiglio; Gerardo Botti; Claudio Arra; Gennaro Ciliberto; Antonello Pessi
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 7.  The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition.

Authors:  Hui-Qiong He; Richard D Ye
Journal:  Molecules       Date:  2017-03-13       Impact factor: 4.411

8.  Targeting Endothelial Barrier Dysfunction Caused by Circulating Bacterial and Mitochondrial N-Formyl Peptides With Deformylase.

Authors:  Patricia Martinez-Quinones; Amel Komic; Cameron G McCarthy; R Clinton Webb; Camilla Ferreira Wenceslau
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

9.  Up-regulated long noncoding RNA AC007128.1 and its genetic polymorphisms associated with Tuberculosis susceptibility.

Authors:  Hong Yan; Guoye Liu; Yuan Liang; Wei Wu; Rui Xia; Lin Jiao; Han Shen; Zhijun Jia; Qian Wang; Zhiqiang Wang; Yi Kong; Binwu Ying; Hualiang Wang; Chengbin Wang
Journal:  Ann Transl Med       Date:  2021-06

10.  Walker 256 Tumor Growth Suppression by Crotoxin Involves Formyl Peptide Receptors and Lipoxin A₄.

Authors:  Patrícia Brigatte; Odair Jorge Faiad; Roberta Cornélio Ferreira Nocelli; Richardt G Landgraf; Mario Sergio Palma; Yara Cury; Rui Curi; Sandra Coccuzzo Sampaio
Journal:  Mediators Inflamm       Date:  2016-04-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.